摘要
目的探讨慢性乙肝患者髓系树突细胞(DCs)表面B7-H1分子在树突细胞介导T细胞免疫应答中的作用。方法受试对象包括46例慢性乙肝患者(11名免疫耐受患者和35名免疫活化患者)和28名健康对照。取外周血,采用流式细胞术检测DCs上B7-H1的表达水平;〔3H〕-TdR掺入试验检测DCs对T淋巴细胞的促增殖效应;ELISA测定混合淋巴细胞培养上清中IFN-γI、L-2I、L-12及IL-10的浓度。结果免疫耐受和免疫活化患者外周血DCs上B7-H1阳性表达率〔(2.21±0.32)%(、7.88±1.40)%〕明显高于健康对照〔(0.35±0.10)%,P<0.01〕。慢性乙肝患者DCs刺激异体T淋巴细胞增殖及产生Ⅰ型细胞因子的能力明显降低,阻断B7-H1共刺激信号途径能够增强患者DCs对T细胞的协同刺激能力。结论慢性乙肝患者外周血DCs上B7-H1表达水平的升高,是导致DCs刺激T淋巴细胞能力下降的一个重要原因。
Objective: To examine the expression of B7-homolog 1(B7-H1) on circulating myeloid dendritic cells(DCs) in patients with chronic hepatitis B virus(HBV) infection and explore its effect on T-cell stimulating capacity of DCs.Methods: The expression of B7-H1 on DCs isolated from forty-six patients with chronic HBV infection,including 11 immune tolerance patients and 35 immune activation patients,and 28 healthy individuals,was determined by FACS(fluorescence-activated cell sorter) gated on Lin1-CD11c+HLA-DR^+ cells.(^3H)-TdR incorporation assay was used to determine proliferation of heterologous T cells stimulated by DCs in mixed lymphocytes reaction(MLR).Concentrations of IFN-γ,IL-2,IL12 and IL-10 in the mixed lymphocytes culture supernatants were examined by ELISA.Results: The positive expression rates in immune tolerance patients,and immune activation patients((2.21±0.32) %,(7.88±1.40)% respectively)were significantly higher than that in healthy subjects((0.35±0.10)%,P〈0.01).The proliferation of heterologous T cells and production of type 1 cytokine stimulated by DCs from patients were significantly decreased.Blockade of B7-H1 on DCs could restore poor T-cell stimulating capacity of DCs.Conclusion: Upregulation of B7-H1 on DCs in patients with hepatitis B virus infection leads to decrease in T-cell stimulating capacity of DCs.
出处
《解放军预防医学杂志》
CAS
北大核心
2007年第5期320-323,共4页
Journal of Preventive Medicine of Chinese People's Liberation Army
基金
国家杰出青年基金项目课题(No.30525042)